Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M R, Emmerling"'
Publikováno v:
Drug and chemical toxicology. 19(1-2)
Tacrine is the first drug approved for the treatment of Alzheimer's disease. Approximately 50% of patients treated with tacrine develop elevated serum aminotransferase levels, as an indication of potential hepatotoxicity. However, acute and chronic s
Publikováno v:
Arzneimittel-Forschung. 45(3A)
Loss of cholinergic function in the neocortex and hippocampus arising from death or atrophy of basal forebrain cholinergic neurons is a consistent feature of the Alzheimer brain at autopsy or biopsy. Replacement of lost cholinergic function, therefor
Autor:
M. R. Emmerling, A. E. Roher
Publikováno v:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents. 3:1-2
Publikováno v:
Critical reviews in neurobiology. 7(1)
The search for novel therapeutics for human cognitive disorders has intensified. Neurotransmitter replacement therapies represent a short-term hope for treating cognitive dysfunction associated with Alzheimer's disease (AD). AD, however, is clearly a
Autor:
C. V. Levenick, S. M. Slapnick, Grayson Scott, Hanna M. Sobkowicz, M. R. Emmerling, J. E. Rose
Publikováno v:
Journal of electron microscopy technique. 15(2)
We have compared the biochemical expression of cholinergic enzymes with the morphological differentiation of efferent nerve fibers and endings in the cochlea of the postnatally developing mouse. Choline acetyltransferase (ChAT) and acetylcholinestera
Autor:
Hanna M. Sobkowicz, M R Emmerling
Publikováno v:
Journal of Neurocytology. 18:209-224
Development of the cholinergic enzymes, choline acetyltransferase (ChAT) and AChE, and of the AChE-positive innervation in the cochlea was studied biochemically and morphologically in the postnatal mouse up to 26 days. Both ChAT and AChE are already